RegPing
Primary sources, polled every 30 minutesJSON · Sitemap · llms.txt · Status

FDA · recall · urgent

FDA: Par Health recalls Argatroban Injection due to particulate matter

Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level due to the presence of particulate matter, identified as cellulose, polystyrene, and polyethylene terephthalate.

Read the notice at fda.gov →

Agency
FDA
Jurisdiction
US-FDA
Action type
recall
Severity
urgent — penalty-bearing, effective immediately, or a serious health hazard
Published
Recorded
Tags
recallargatrobanparticulate-matterinjectable
Not legal advice. RegPing republishes and summarizes public regulator notices and links to the original. Summaries are produced with a language model and can be wrong; the regulator's text controls. Not legal advice. Consult counsel before acting.

More from FDA

Everything from week 2026-W42 · All FDA alerts